Korean Guidelines for Pharmacoeconomic Evaluation (Second and Updated Version) SeungJin BaeSooOk LeeSunmee Jang Practical Application 16 January 2013 Pages: 257 - 267
Bivalirudin for the Treatment of ST-Segment Elevation Myocardial Infarction: A NICE Single Technology Appraisal E. L. SimpsonP. FitzgeraldA. Bakhai Review Article 20 March 2013 Pages: 269 - 275
A Systematic Review of Utility Values for Chemotherapy-Related Adverse Events Fatiha H. ShabaruddinLi-Chia ChenKatherine Payne Systematic Review 26 March 2013 Pages: 277 - 288
Model-Based Cost-Effectiveness Analyses for Prostate Cancer Chemoprevention Stephanie R. EarnshawAndrew P. BroganCheryl L. McDade Systematic Review 22 March 2013 Pages: 289 - 304
Using a Discrete Choice Experiment to Elicit Time Trade-Off and Willingness-to-Pay Amounts for Influenza Health-Related Quality of Life at Different Ages Lisa A. ProsserKatherine PayneMark Messonnier Original Research Article 20 March 2013 Pages: 305 - 315
The Cost Effectiveness of Pharmacological Treatments for Generalized Anxiety Disorder Ifigeneia MavranezouliNick MeaderTim Kendall Original Research Article 20 March 2013 Pages: 317 - 333
Temporary Authorization for Use: Does the French Patient Access Programme for Unlicensed Medicines Impact Market Access After Formal Licensing? Albane Degrassat-ThéasPascal PaubelMartine Sinègre Original Research Article 26 March 2013 Pages: 335 - 343
Decision-Makers’ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External Validity Warren G. LinleyDyfrig A. Hughes Original Research Article 21 March 2013 Pages: 345 - 355